Acasti Pharma Inc (ACST)

0.5835
+0.0222(+3.96%)
After Hours
0.5800
-0.0035(-0.5998%)
- Real-time Data
  • Volume:
    47,414
  • Day's Range:
    0.5802 - 0.6008
  • 52 wk Range:
    0.5500 - 1.9800

ACST Overview

Prev. Close
0.5613
Day's Range
0.5802-0.6008
Revenue
-
Open
0.5936
52 wk Range
0.55-1.98
EPS
-0.271
Volume
47,414
Market Cap
26.07M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
68,839
P/E Ratio
-2.83
Beta
1.38
1-Year Change
-70.97%
Shares Outstanding
44,506,330
Next Earnings Date
Nov 16, 2022
What is your sentiment on Acasti Pharma?
or
Market is currently closed. Voting is open during market hours.

Acasti Pharma Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Acasti Pharma Inc Analysis

Acasti Pharma Inc Company Profile

Acasti Pharma Inc Company Profile

Employees
32
Market
Canada

Acasti Pharma Inc. is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: Subarachnoid Hemorrhage (SAH), Ataxia Telangiectasia (A-T), and Postherpetic Neuralgia (PHN). The Company's lead product candidate includes GTX-104, which is a clinical-stage nanoparticle formulation of nimodipine being developed for IV infusion in SAH patients. The Company's other pipeline products include GTX-102, an oral mucosal spray formulation of betamethasone intended to develop neurological symptoms of A-T, including developing clinical assessments of posture and gait disturbance, and kinetic speech and oculomotor functions. GTX-101 is a topical bio-adhesive film-forming spray of bupivacaine for the treatment of PHN.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellNeutralStrong SellStrong Sell
SummaryStrong SellStrong SellSellStrong SellStrong Sell
  • any1?
    0
    • what happened?!
      0
    • thats what I'm asking but I'll take it
      0
    • just quoted for 6$
      0
  • As i mention company will file bankrupt at the end 2021
    2
    • Greetings. Please give me a specific reason why this company will bankrupt.
      0
    • 35% on top. Ok bro
      0
  • Does anyone know when this stock can be sold.
    0
    • the only thing I can see it will go up someday. no one can know that. maybe it will go back to 0,4 usd before explosion 💥
      0
  • It will hold, will go up.
    0
    • It will bankrupt soon
      2
      • Defently not. The company has a lot money.Current Ratio = 25.75https://finance.yahoo.com/quote/ACST/key-statistics?p=ACST
        0
    • I think this stock will explode soon
      0
      • Ruuuuuuun
        0
        • With all respect and no hard feelings. RUN
          0
          • Reverse split 8:1 on August 31st. will bring 3.2$ price. After that will fall ~40% to 2$.
            0
            • how did you know so exactly
              0
            • https://seekingalpha.com/news/3734849-acasti-pharma-to-effect-8-1-reverse-stock-split-closes-grace-therapeutics-merger
              0
          • 15 days left, the rocket is near! BUY
            1
            • means?
              0